[{"Assets_0_Q2_USD":139382000.0,"CommonStockSharesOutstanding_0_Q2_shares":47799138.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-38884000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q2_USD":-14197000.0,"NetIncomeLoss_2_Q2_USD":4830000.0,"NetIncomeLoss_1_Q2_USD":-17071000.0,"StockholdersEquity_0_Q2_USD":108514000.0,"EarningsPerShareBasic_2_Q2_USD":0.12,"EarningsPerShareBasic_1_Q2_USD":-0.36,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":39051958.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":47708085.0,"Ticker":"MRSN","CIK":"1442836","name":"MERSANA THERAPEUTICS, INC.","OfficialName":"Mersana Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"345233797.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]